Pacifichealth Laboratories Stock Earnings Per Share
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Earnings Per Share Analysis
PacificHealth Laboratories' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current PacificHealth Laboratories Earnings Per Share | (0.04) X |
Most of PacificHealth Laboratories' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, PacificHealth Laboratories has an Earnings Per Share of -0.045 times. This is 102.62% lower than that of the Personal Products sector and 104.21% lower than that of the Consumer Staples industry. The earnings per share for all United States stocks is 101.44% higher than that of the company.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
PacificHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 571.89 K | ||||
| Shares Outstanding | 20.87 M | ||||
| Price To Earning | (0.34) X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 6.91 M | ||||
| Gross Profit | 2.99 M | ||||
| EBITDA | (861.23 K) | ||||
| Net Income | (486.31 K) | ||||
| Cash And Equivalents | 324.48 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 54.86 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (503.96 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.8 | ||||
| Beta | -275.06 | ||||
| Market Capitalization | 87 | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (20.59 M) | ||||
| Working Capital | 676 K | ||||
| Current Asset | 1.84 M | ||||
| Current Liabilities | 1.17 M | ||||
| Z Score | -11.0 | ||||
| Net Asset | 1.89 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |